Therapeutic Mechanisms of Hookworm Excretory-Secretory Products in MTHFR C677T/A1298C Variants
A mechanistic account of how Necator americanus ES products intersect established MTHFR–homocysteine pathophysiology — and where the coupling remains conjectural
Stephen Michael Nenninger, N.M.D.
1. Statement of the observation
Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR), principally C677T and A1298C, reduce enzymatic conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, impair remethylation of homocysteine to methionine, and, under low-folate conditions, produce mild to moderate hyperhomocysteinemia with downstream oxidative stress, endothelial dysfunction, and chronic low-grade inflammation.
12
Therapeutic colonization with the human hookworm Necator americanus, and exposure of host tissues to its excretory-secretory products (ESPs), expand regulatory T cells, induce IL-10 and TGF-β, remodel dendritic-cell tone, and suppress selected proinflammatory circuits in humans and in experimental models.
345
The clinical question is whether those immunomodulatory and antioxidant-adjacent ESP activities can blunt the inflammatory and endothelial consequences of MTHFR-associated hyperhomocysteinemia. The literature supports a clear intersection at the level of cytokine and endothelial inflammatory signaling. Claims that ESPs directly correct one-carbon flux, restore SAM balance, or detoxify homocysteine itself are not established and are marked as conjecture below.
2. Biochemistry of MTHFR C677T/A1298C and hyperhomocysteinemia
MTHFR catalyzes the NADPH-dependent reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the principal circulating folate and the methyl donor for methionine synthase–mediated remethylation of homocysteine to methionine. The C677T (Ala222Val) substitution produces a thermolabile enzyme; homozygotes show substantially reduced residual activity and elevated plasma homocysteine when folate status is low.
1
The A1298C (Glu429Ala) variant independently lowers lymphocyte MTHFR activity; compound heterozygotes for C677T and A1298C typically retain about 50–60% of control activity.
2
Neither variant is a diagnosis. Both are risk modifiers whose biochemical expression depends on folate, cobalamin, riboflavin, and methionine intake.
Elevated homocysteine injures endothelium by several convergent routes. Homocysteine increases superoxide production, activates IκB kinases, drives IκBα degradation, and promotes NF-κB nuclear translocation in endothelial cells in vivo and in culture; superoxide scavengers and IKK inhibitors interrupt that cascade.
6
Homocysteine also favors endothelial nitric-oxide synthase (eNOS) uncoupling through oxidation of the cofactor tetrahydrobiopterin (BH4), accumulation of asymmetric dimethylarginine (ADMA), and NADPH-oxidase–dependent ROS, reducing nitric-oxide bioavailability and generating peroxynitrite.
7
The resulting endothelial phenotype — adhesion-molecule upregulation, cytokine release (IL-1β, IL-6, TNF-α), impaired vasodilation, and a prothrombotic surface — is the pathophysiology that any ESP-based account of “benefit” in MTHFR variants must address. It is an inflammatory and redox problem downstream of impaired remethylation, not a problem that ESP proteins have been shown to reverse by restoring MTHFR itself.
3. What hookworm ESPs actually contain that could matter
Adult and larval N. americanus secrete a stage-specific cocktail of proteins, peptides, lipids, glycans, metabolites, and extracellular vesicles on the order of two hundred excreted/secreted proteins in proteomic surveys.
8932
The N. americanus genome encodes an expanded set of immunomodulators: ASP/SCP-TAPS proteins, TIMP-like netrin-domain proteins, glutathione S-transferases, galectins, macrophage migration inhibitory factors, and TGF-β homologues.
10
Several named effectors have defined mammalian activities:
- Na-AIP-1 (netrin-domain / TIMP-like) suppresses TNF release from human M1 macrophages, requires CD11c+ cells for anticolitic activity, and protects in TNBS and T-cell-transfer colitis.
11
- Ac-AIP-2 (formerly Ac-TMP-2), a related TIMP-like protein from Ancylostoma caninum, expands regulatory T cells via mesenteric CD103+ dendritic cells and suppresses experimental asthma.
12
- Ac-TMP-1 / Ac-AIP-1 modifies dendritic-cell MHC and cytokine profiles and drives generation of IL-10–producing CD4+ and CD8+ Foxp3+ suppressor T cells.
13
Despite sequence homology to mammalian TIMPs, these hookworm proteins do not appear to inhibit matrix metalloproteinases; their netrin domains perform immunomodulatory functions distinct from classical MMP blockade.
14
- Na-ASP-2 adopts a chemokine-like fold, recruits neutrophils, and down-regulates B-cell receptor signaling through CD79A.
1516
It is not the CD11b/CD18 ligand. That activity belongs to neutrophil inhibitory factor (NIF) from A. caninum, which binds CD11b/CD18, blocks neutrophil adhesion, and reduces H2O2 release; divergent NIF-like sequences exist in N. americanus ESTs but are less well characterized.
17
- Na-GST-1 is a nu-class glutathione S-transferase recovered from adult ES products. It binds heme and hematin with high affinity and shows limited peroxidase activity against model carbonyl substrates; its established biology is blood-meal detoxification, not host-homocysteine chemistry.
1833
- Metalloproteases in N. americanus ES products specifically cleave eotaxin and block eotaxin-driven eosinophil recruitment.
19
- Acetylcholinesterase is secreted by adult N. americanus into ES products and can be affinity-purified from culture medium; its physiologic host target in vivo remains incompletely defined.
20
- Low-molecular-weight ESP fractions from A. caninum contain short-chain fatty acids (acetate, propionate, butyrate, isobutyrate, branched C5 acids) and suppress colitis pathology and human leukocyte inflammatory cytokines.
21
Whether those SCFAs are worm-synthesized or microbiome-derived remains unresolved. - Extracellular vesicles deliver nematode miRNAs into mammalian cells, repress targets such as Dusp1 and Il33r, and suppress experimental colitis.
22
These are the molecules for which real evidence exists. Any MTHFR-facing mechanism must be built from them, not from invented ESP ligands.
4. Immunomodulation axis: Treg, IL-10, TGF-β, and NF-κB-relevant cytokines
The strongest ESP–host literature intersects MTHFR pathophysiology precisely where hyperhomocysteinemia drives NF-κB–dependent cytokine amplification.
Natural human hookworm colonization expands circulating CD4+CD25+FOXP3+ regulatory T cells that produce IL-10 and TGF-β and that restrain antigen-driven lymphocyte proliferation.
3
Controlled colonization remodels plasmacytoid dendritic cells and raises Treg frequencies; naturally acquired infection further increases Treg expression of ICOS, TNFR2, and TGF-β latency-associated peptide and raises in-vitro suppressive capacity.
4
In experimental human colonization of celiac disease, mucosal IL-10 and TGF-β rise and the gluten response shifts away from Th1/Th17 toward Th2.
523
Hookworm ES products induce IL-4+IL-10+CD4+ T cells and suppress pathology in murine colitis.
24
Helminth TGF-β mimics such as Hp-TGM bind TβRI and TβRII directly and drive Foxp3 induction; related family members act as cell-type-restricted agonists or antagonists.
25
Protein effectors map onto the same circuit. Ac-TMP-1–pulsed dendritic cells generate IL-10–producing CD4+ and CD8+ Foxp3+ suppressors.
13
Ac-AIP-2 expands Tregs and reduces co-stimulatory markers on human dendritic cells.
12
Na-AIP-1 increases IL-10 and TGF-β while reducing TNF, IL-13, and IL-17A in colitis models.
11
ShK-like peptides Acan1 and Nak1 suppress CD4+ proliferation and IL-2 and TNF and protect against experimental colitis.
26
Homocysteine-activated endothelium and leukocytes overproduce the same proinflammatory mediators — TNF-α, IL-1β, IL-6, IFN-γ-associated programs — that these ESP pathways suppress.
67
That is an established mechanistic overlap: ESP-driven Treg/IL-10/TGF-β tone opposes Hcy-driven NF-κB cytokine tone. It is not evidence that ESPs lower plasma homocysteine or restore 5-methyl-THF.
5. Oxidative and endothelial axes
Two ESP activities speak directly to leukocyte-driven oxidative injury at endothelial surfaces.
First, NIF engagement of CD11b/CD18 inhibits neutrophil adhesion to endothelium and reduces hydrogen-peroxide release over a nanomolar range.
17
In a host whose endothelium is already primed by homocysteine-derived superoxide and peroxynitrite, limiting integrin-dependent neutrophil effector function is a coherent, literature-supported countermeasure — provided one names NIF (or NIF-like products), not Na-ASP-2.
Second, Na-AIP-1 and related AIP/TIMP-like proteins suppress macrophage TNF and protect barrier tissues in colitis models that share endothelial and epithelial permeability failure with chronic inflammatory vasculopathy.
1112
Metalloprotease cleavage of eotaxin further reduces eosinophil recruitment.
19
EVs and ES proteins collectively dampen innate inflammatory tone.
2224
Separately, host glutathione peroxidase overexpression rescues homocysteine-induced endothelial dysfunction by preserving nitric-oxide bioavailability.
27
That finding clarifies why redox capacity matters in HHcy. It does not demonstrate that secreted Na-GST-1 substitutes for host GPx-1. Na-GST-1’s documented role is heme binding and limited glutathione conjugation in the parasite’s blood-feeding niche.
18
Any claim that Na-GST-1 detoxifies “homocysteine-derived electrophiles” or 4-hydroxynonenal in human plasma is extrapolation beyond the available enzymology and is treated as conjecture in Section 9.
6. Metabolic, epigenetic, and SCFA angles — literature versus conjecture
Established. Low-molecular-weight fractions of hookworm somatic extracts and ES products contain SCFAs, including propionate, acetate, isobutyrate, and butyrate, and those fractions suppress TNBS colitis and LPS-driven cytokine release from human leukocytes.
21
Butyrate is a well-characterized class I/II HDAC inhibitor that down-regulates proinflammatory mediators (including nitric oxide, IL-6, and IL-12) in intestinal macrophages independent of TLR and SCFA-GPCR signaling.
28
Experimental N. americanus colonization can increase microbial species richness; in celiac volunteers under gluten challenge, hookworm infection was associated with maintained flora composition and increased richness, a microbiota context in which host SCFA tone may shift.
2930
Conjectural — explicitly. From those facts it is tempting to argue that ESP- or microbiota-derived butyrate (i) increases SAM availability by HDAC-linked epigenetic reprogramming, (ii) upregulates folate-receptor expression, and (iii) thereby compensates for MTHFR hypofunction. No peer-reviewed study demonstrates that hookworm colonization or ESP administration restores 5-methyl-THF, lowers fasting homocysteine, or increases folate-receptor abundance via butyrate in MTHFR-variant humans. HDAC inhibition and anti-inflammatory SCFA biology are real; the one-carbon compensation loop is a hypothesis, not a finding.
Also conjectural. Acetylcholinesterase in N. americanus ES products is real.
20
The further claim that ESP AChE enhances vagal anti-inflammatory reflexes and thereby activates hepatic cystathionine β-synthase to clear homocysteine via transsulfuration has no direct experimental support and is not asserted here.
7. Autoimmune and neurological implications — carefully hedged
MTHFR variants and hyperhomocysteinemia have been associated, with varying strength of evidence, with vascular risk and with heterogeneous autoimmune and neuropsychiatric phenotypes. Hookworm and ESP immunology speaks most clearly to autoimmune inflammation.
In relapsing multiple sclerosis, a randomized placebo-controlled trial of 25 N. americanus larvae (WIRMS) did not meet its primary MRI lesion endpoint by the preplanned analysis, but zero-activity MRI scans were more frequent with hookworm (51% vs 28%), relapses were fewer (5 vs 11), and CD4+CD25highCD127neg Treg percentages rose significantly.
31
That is a signal of immunobiological effect, not a claim of disease modification or cure. In colitis and asthma models, recombinant AIP proteins and whole ES products prevent Th1/Th17-dominant pathology and expand suppressor T cells.
11121324
Tolerogenic dendritic-cell induction and CD4+/CD8+ suppressor generation by Ac-TMP-1 are established in mice.
13
Extension of those findings to rheumatoid arthritis or to “MTHFR-linked autoimmunity” as a class remains inferential.
For neuropsychiatric sequelae sometimes attributed to impaired BH4-dependent neurotransmitter synthesis under hyperhomocysteinemia, the ESP literature does not supply direct evidence that hookworm metabolites raise BDNF, restore serotonergic tone, or repair COMT methylation. Those claims appeared in earlier short-form site copy and are refused here for lack of evidence. Indirect benefit — if it occurs — would have to travel through reduced systemic inflammatory cytokine load and improved endothelial/redox status, not through demonstrated monoamine enzymology.
8. Conjectural mechanism: coupled loops
The following three-loop model organizes how established ESP immunology could, in principle, blunt MTHFR-associated inflammatory injury. Loops 1 and 2 rest on published data. Loop 3 is the conjectural coupling to one-carbon metabolism.
Loop 1 — Inflammatory set-point reset (established).
Colonizing N. americanus and its ESPs expand FOXP3+ Tregs, raise IL-10 and TGF-β, induce tolerogenic dendritic cells, and suppress TNF, IL-6, IFN-γ–associated programs, and selected innate effector functions (neutrophil integrin blockade via NIF-class proteins; eotaxin cleavage; EV-miRNA repression of innate targets).
3411121317192224
That reset opposes the NF-κB–cytokine amplification that homocysteine triggers in endothelium.
6
Loop 2 — Barrier and oxidative load reduction (partly established).
Reduced leukocyte adhesion and ROS output at the endothelial interface, together with macrophage TNF suppression and mucosal barrier support in colitis models, lowers the oxidative feedback that sustains eNOS uncoupling and peroxynitrite formation.
71117
Host antioxidant capacity (e.g., GPx-1) remains the primary enzymatic defense against Hcy-induced endothelial dysfunction;
27
ESP contributions are immunomodulatory and anti-recruitment, not proven GST substitution.
Loop 3 — Metabolic feedback into one-carbon chemistry (conjectural).
If ESP- and microbiota-associated SCFAs, HDAC inhibition, and chronic IL-10/TGF-β tone secondarily improve hepatic and endothelial redox tone, demand on the remethylation pathway could fall and residual MTHFR activity might suffice under adequate folate. Alternatively, SCFA-driven epigenetic change might alter expression of folate transporters or transsulfuration enzymes. Neither alternative has been measured in hookworm-treated MTHFR-variant cohorts. Loop 3 is a research program, not a clinical claim.
Testable predictions follow. Recipients of therapeutic N. americanus who carry C677T or A1298C should be assayed, before and after stable colonization, for fasting and post-methionine-load homocysteine, 5-methyl-THF, SAM/SAH ratio, circulating LAP+ Tregs, endothelial function (flow-mediated dilation), and fecal SCFA profiles. A fall in inflammatory cytokines without a fall in homocysteine would support Loops 1–2 alone. Concurrent improvement in one-carbon metabolites would begin to support Loop 3.
9. Practical clinical framing without overclaiming cure
Controlled hookworm therapy is not a substitute for folate, methylfolate, cobalamin, riboflavin, or pyridoxine repletion in patients with symptomatic hyperhomocysteinemia. It is not an approved treatment for MTHFR-related vascular disease, autoimmunity, or psychiatric illness. What the evidence does support is that N. americanus colonization and defined ESP proteins engage regulatory immune circuits that counteract the inflammatory and leukocyte-oxidative arms of homocysteine toxicity, with a mild immunobiological signal in one relapsing-MS randomized trial and robust preclinical protection in colitis and asthma models.
11122431
In clinical practice, the mechanistic framing is therefore adjunctive and hypothesis-generating: in a host whose MTHFR genotype predisposes to Hcy-amplified NF-κB and endothelial ROS, a stable hookworm colony may lower the inflammatory gain on that circuit. Monitoring should remain biochemical and clinical — homocysteine, folate status, inflammatory markers, and disease-specific endpoints — not marketing claims of enzymatic repair. Peptide- or autologous-serum–conditioned larvae, discussed on companion pages, are strategies for loading Loop 1 earlier; they do not create a new MTHFR enzyme.
References
1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113. doi:10.1038/ng0595-111.
2. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169–172. doi:10.1006/mgme.1998.2714.
3. Ricci ND, Fiúza JA, Bueno LL, Cançado GGL, Gazzinelli-Guimarães PH, Martins VG, Matoso LF, de Miranda RRC, Geiger SM, Correa-Oliveira R, Gazzinelli A, Bartholomeu DC, Fujiwara RT. Induction of CD4+CD25+FOXP3+ regulatory T cells during human hookworm infection modulates antigen-mediated lymphocyte proliferation. PLoS Negl Trop Dis. 2011;5(11):e1383. doi:10.1371/journal.pntd.0001383.
4. Driciru E, Koopman JPR, et al. Controlled human hookworm infection remodels plasmacytoid dendritic cells and regulatory T cells towards profiles seen in natural infections in endemic areas. Nat Commun. 2024;15:5472. doi:10.1038/s41467-024-50313-0. (Often cited in site materials as de Ruiter / controlled-colonization Treg–pDC remodeling.)
5. McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, Ruyssers NE, Speare R, McCarthy JS, Engwerda CR, Croese J, Loukas A. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One. 2011;6(9):e24092. doi:10.1371/journal.pone.0024092.
6. Au-Yeung KK, Woo CW, Sung FL, Yip JC, Siow YL, O K. Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress. Circ Res. 2004;94(1):28–36. doi:10.1161/01.RES.0000108264.67601.2c.
7. Cheng Z, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev. 2009;5(2):158–165. doi:10.2174/157340209788166940. See also: Steed MM, Tyagi SC. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal. 2011;15(7):1927–1943. doi:10.1089/ars.2010.3721. PMC3159179.
8. Logan J, Pearson MS, Manda SS, et al. Comprehensive analysis of the secreted proteome of adult Necator americanus hookworms. PLoS Negl Trop Dis. 2020;14(5):e0008237. doi:10.1371/journal.pntd.0008237. PMC7274458.
9. Abuzeid AMI, Zhou X, Huang Y, Li G. Twenty-five-year research progress in hookworm excretory/secretory products. Parasit Vectors. 2020;13:136. doi:10.1186/s13071-020-04010-8. PMC7071665.
10. Tang YT, Gao X, Rosa BA, et al. Genome of the human hookworm Necator americanus. Nat Genet. 2014;46(3):261–269. doi:10.1038/ng.2875.
11. Buitrago G, Pickering D, Ruscher R, et al. A netrin domain-containing protein secreted by the human hookworm Necator americanus protects against CD4 T cell transfer colitis. Transl Res. 2021;232:88–102. doi:10.1016/j.trsl.2021.02.012. (Na-AIP-1; CD11c-dependent anticolitic effect; TNF suppression in human M1 macrophages.) Related: Ferreira I, Pickering D, Troy S, Croese J, Loukas A, Navarro S. Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis. Clin Transl Immunology. 2017;6(10):e157. doi:10.1038/cti.2017.42. PMC5671989.
12. Navarro S, Pickering DA, Ferreira IB, et al. Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma. Sci Transl Med. 2016;8(362):362ra143. doi:10.1126/scitranslmed.aaf8807.
13. Cuéllar C, Wu W, Mendez S. The hookworm tissue inhibitor of metalloproteases (Ac-TMP-1) modifies dendritic cell function and induces generation of CD4 and CD8 suppressor T cells. PLoS Negl Trop Dis. 2009;3(5):e439. doi:10.1371/journal.pntd.0000439.
14. Cobos C, Bansal PS, Wilson DT, et al. Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells. Front Med (Lausanne). 2022;9:934852. doi:10.3389/fmed.2022.934852. (Notes absence of classical MMP-inhibitory activity in AIP/TIMP-like hookworm proteins; helical AIP-derived peptides.)
15. Asojo OA, Goud G, Dhar K, et al. X-ray structure of Na-ASP-2, a pathogenesis-related-1 protein from the nematode parasite Necator americanus, and its ligand-binding site. J Mol Biol. 2005;346(3):801–814. doi:10.1016/j.jmb.2004.12.023.
16. Tribolet L, Cantacessi C, Pickering DA, et al. Probing of a human proteome microarray with a recombinant pathogen protein reveals a novel mechanism by which hookworms suppress B-cell receptor signaling. J Infect Dis. 2015;211(3):416–425. doi:10.1093/infdis/jiu451. (Na-ASP-2–CD79A.)
17. Moyle M, Foster DL, McGrath DE, et al. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J Biol Chem. 1994;269(13):10008–10015. doi:10.1016/S0021-9258(17)36982-X.
18. Zhan B, Perally S, Brophy PM, et al. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect Immun. 2010;78(4):1552–1563. doi:10.1128/IAI.00848-09. PMC2849424.
19. Culley FJ, Brown A, Conroy DM, Sabroe I, Pritchard DI, Williams TJ. Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J Immunol. 2000;165(11):6447–6453. doi:10.4049/jimmunol.165.11.6447.
20. Pritchard DI, Leggett KV, Rogan MT, McKean PG, Brown A. Necator americanus secretory acetylcholinesterase and its purification from excretory-secretory products by affinity chromatography. Parasite Immunol. 1991;13(2):187–199. doi:10.1111/j.1365-3024.1991.tb00274.x.
21. Wangchuk P, Shepherd C, Constantinoiu C, et al. Hookworm-derived metabolites suppress pathology in a mouse model of colitis and inhibit secretion of key inflammatory cytokines in primary human leukocytes. Infect Immun. 2019;87(4):e00851-18. doi:10.1128/IAI.00851-18. PMC6434117.
22. Buck AH, Coakley G, Simbari F, et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488. doi:10.1038/ncomms6488. Eichenberger RM, Ryan S, Jones L, et al. Hookworm secreted extracellular vesicles interact with host cells and prevent inducible colitis in mice. Front Immunol. 2018;9:850. doi:10.3389/fimmu.2018.00850.
23. Croese J, Giacomin P, Navarro S, et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol. 2015;135(2):508–516. doi:10.1016/j.jaci.2014.07.022. Gaze S, McSorley HJ, Daveson J, et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog. 2012;8(2):e1002520. doi:10.1371/journal.ppat.1002520.
24. Ferreira I, Smyth D, Gaze S, et al. Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun. 2013;81(6):2104–2111. doi:10.1128/IAI.00563-12.
25. Johnston CJC, Smyth DJ, Dresser DW, et al. A structurally distinct TGF-β mimic from an intestinal helminth potently induces regulatory T cells. Nat Commun. 2017;8:1741. doi:10.1038/s41467-017-01886-6.
26. Cobos Caceres C, Bansal PS, Jones LM, et al. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo. J Biol Chem. 2021;297(1):100834. doi:10.1016/j.jbc.2021.100834. (Acan1, Nak1 ShK-like peptides.)
27. Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci USA. 2001;98(22):12503–12508. doi:10.1073/pnas.231428998. PMC60083.
28. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111(6):2247–2252. doi:10.1073/pnas.1322269111. PMC3926023.
29. Cantacessi C, Giacomin P, Croese J, et al. Impact of experimental hookworm infection on the human gut microbiota. J Infect Dis. 2014;210(9):1431–1434. doi:10.1093/infdis/jiu256.
30. Giacomin P, Zakrzewski M, Croese J, et al. Experimental hookworm infection and escalating gluten challenges are associated with increased microbial richness in celiac subjects. Sci Rep. 2015;5:13797. doi:10.1038/srep13797.
31. Tanasescu R, Tench CR, Constantinescu CS, et al. Hookworm treatment for relapsing multiple sclerosis: a randomized double-blinded placebo-controlled trial. JAMA Neurol. 2020;77(9):1089–1098. doi:10.1001/jamaneurol.2020.1118. PMC7296452.
32. Loukas A, Hotez PJ, Diemert D, et al. Hookworm infection. Nat Rev Dis Primers. 2016;2:16088. doi:10.1038/nrdp.2016.88.
33. Brophy PM, Pritchard DI. Parasitic helminth glutathione S-transferases: an update on their potential as targets for immuno- and chemotherapy. Exp Parasitol. 1994;79(1):89–96. (Background on helminth GST detoxification biology.)